Dr. Putcha on the Utility of Blood-Based Assays in CRC
Girish Putcha, MD, PhD, discusses the utility of blood-based assays in colorectal cancer.
Dr. Putcha on the Results of the AI EMERGE Trial in CRC
Girish Putcha, MD, PhD, discusses the results of the AI EMERGE trial (NCT03688906) in colorectal cancer.
Dr. Putcha on Blood-Based Detection of Early-Stage CRC
Girish Putcha, MD, PhD, chief medical officer and clinical laboratory director, Freenome, discusses blood-based detection of early-stage colorectal cancer (CRC) using multiomics and machine learning.
Dr. Putcha on the Use of Blood-Based Screening Assays in CRC
Girish Putcha, MD, PhD, discusses the use of blood-based screening assays in colorectal cancer (CRC).
Immunotherapy Must Become More Precise and Personalized in Lung Cancer
Selecting the Appropriate CAR T-Cell Therapy for Patients with R/R LBCL
Is There a Potential Role for Rapcabtagene Autoleucel in R/R LBCL?
PD-1 Inhibitor Combinations, Alternative Therapeutic Approaches Are Moving the Needle in NSCLC
2 Clarke Drive Cranbury, NJ 08512